Ironwood Pharmaceuticals, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 22,881 150,245 65,871 43,857
Cost of Revenue 7,203 965 - -
Gross Profit 15,678 149,280 65,871 43,857
Operating Expenses
Research and Development 102,378 113,474 86,093 77,454
Sales, General and Admin. 165,302 108,568 45,920 27,169
Non-Recurring Items - - - -
Other - - - -
Operating Income (252,002) (72,762) (66,142) (60,766)
Income From Continuing Operations
Add'l Income/Expense Items 192 197 1,356 1,607
Earnings Before Interest and Tax (251,810) (72,565) (64,786) (59,159)
Interest Expense 21,002 59 63 196
Earnings Before Tax (272,812) (72,624) (64,849) (59,355)
Income Tax - - 3 (2,944)
Minority Interest - - - 1,121
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (272,812) (72,624) (64,852) (56,411)
Non Recurring Events
Discontinued Operations - - - 4,551
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (272,812) (72,624) (64,852) (52,981)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (272,812) (72,624) (64,852) (52,981)